AI Designed by FOEDRC Member Michael Abramoff Conducted Clinical Trial

The system designed by Dr. Michael Abramoff using artificial intelligence (AI) to detect diabetic retinopathy earned Food and Drug Administration (FDA) authorization in April, after a clinical trial in primary care offices.

Click Here to read the full article.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close